Vectura

Medtechs opened 2021 with a flurry of M&A and have not stopped spending since
Medtech Dive
Fri, 10/8/21 - 10:55 am
devices
Medtech
M&A
Boston Scientific
Baylis Medical
GE Healthcare
BK Medical
Devoro Medical
Philip Morris
Vectura
Vectura board says it will unanimously back a Philip Morris takeover
Endpoints
Fri, 08/13/21 - 10:58 am
Vectura
M&A
Philip Morris
Bidding war breaks out for respiratory specialist Vectura
Pharmaforum
Sun, 08/8/21 - 11:49 pm
Vectura
M&A
Carlyle
Philip Morris
Vectura's $1.45B sale to tobacco giant Philip Morris under fire from British business secretary: report
Fierce Pharma
Wed, 07/14/21 - 10:33 pm
Vectura
Philip Morris
M&A
UK
Kinaset launches with $40M and a JAK inhibitor from Vectura's old pipeline
Endpoints
Mon, 11/30/20 - 10:20 am
Kinaset Therapeutics
asthma
Vectura
JAK inhibitors
UK's Vectura wins patent infringement case against GlaxoSmithKline in U.S.
Yahoo/Reuters
Sat, 05/4/19 - 04:36 pm
Vectura
GSK
patents
Vectura’s Severe Asthma Treatment Fails in Phase III Trial
BioSpace
Mon, 11/26/18 - 12:40 pm
Vectura
VR475
drug-device combos
devices
severe asthma
Vectura to advance asthma inhaler after phase 2 studies show ease of use by young children
Fierce Biotech
Wed, 08/22/18 - 06:02 pm
Vectura
asthma
inhalers
VR647
pediatrics
GlaxoSmithKline eyes $1.7B bid for respiratory partner Vectura: report
Fierce Pharma
Tue, 01/16/18 - 07:00 pm
GSK
Vectura
respiratory disease
M&A
GSK seeks to protect Advair through GBP1.2bn acquisition of Vectura
GoinPharma
Sat, 01/13/18 - 01:59 pm
GSK
Advair
Vectura
M&A
Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura
Fierce Pharma
Thu, 05/11/17 - 11:49 am
GSK
FDA
Advair
Hikma
Vectura
Trial failure dashes Vectura's hopes for wider use of asthma drug
BioPharma Dive
Wed, 08/31/16 - 09:10 am
Vectura
asthma
clinical trials
Flutiform
AstraZeneca loses second top executive as Vectura gets new CEO
Yahoo/Reuters
Wed, 06/24/15 - 08:21 am
AstraZeneca
Vectura
Britain's Vectura collaborates with Janssen in asthma, COPD
Yahoo/Reuters
Tue, 01/6/15 - 08:44 am
Janssen
JNJ
Vectura
asthma
COPD
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Vectura gets new U.S. partner for copy of lung drug
Reuters
Wed, 08/3/11 - 11:10 am
Vectura
GSK
generics
Advair
VR315
Vectura Licenses Patents To GlaxoSmithKline
WSJ Online
Fri, 08/6/10 - 07:57 am
Vectura
licensing
GSK
Glaxo's Asthma Drug Looks Increasingly Bullet-Proof
Seeking Alpha
Sat, 03/20/10 - 11:34 am
GSK
asthma
Vectura
Sandoz
generics
Advair
Vectura blueprints late-stage trials for key drugs
Fierce Biotech
Tue, 05/19/09 - 08:07 pm
Vectura
Novartis
pipelines
Vectura benefits from moving up ranks
FT.com
Mon, 05/4/09 - 07:20 pm
Vectura